 Biotech innovator GB Sciences has launched a drug discovery platform using AI technology that can identify and predict the efficacy of combinations of novel active ingredients from plants. LAS VEGAS, NV ACCESSWIRE June 29, 2021 GB Sciences OTCQB:GBLX is leading the way in cutting-edge biopharmaceutical research with its novel AI-accelerated drug discovery platform-PhAROSTM - Phytomedical Analytics for Research Optimization at Scale. 